Which anxiolytic medications are effective without causing hyperhidrosis?

Anxiolytic Medications with Lower Risk of Hyperhidrosis

For anxiety treatment without causing sweating, consider buspirone, fluvoxamine, bupropion, or vortioxetine as first-line options, as these agents are not associated with increased hyperhidrosis risk, unlike most SSRIs and SNRIs.

Medications That DO NOT Cause Increased Sweating

The following anxiolytic agents showed no significant increase in hyperhidrosis compared to placebo in meta-analysis:

• Fluvoxamine (RR = 0.56,95% CI: 0.12-2.53) - actually showed lower sweating rates than placebo 1
• Bupropion (RR = 1.23,95% CI: 0.57-2.67) - no significant increase 1
• Vortioxetine (RR = 1.35,95% CI: 0.79-2.33) - no significant increase 1
• Buspirone - lacks the side effect profile of benzodiazepines and has minimal adverse effects, with dizziness, nervousness, and headaches being most common (no sweating reported) 2
• Hydroxyzine - an antihistamine anxiolytic primarily associated with drowsiness/sleepiness rather than sweating 3, 4

Medications That DO Cause Increased Sweating

Avoid these if hyperhidrosis is a concern:

• SSRIs (except fluvoxamine): Paroxetine, sertraline, escitalopram, citalopram, and fluoxetine all significantly increase hyperhidrosis risk (pooled RR = 2.93,95% CI: 2.46-3.47) 1
• SNRIs: Venlafaxine and other SNRIs show similar sweating risk (RR = 3.17,95% CI: 2.63-3.82) 1
• The increased sweating risk with SSRIs/SNRIs is associated with dopamine transporter affinity, not dose-dependent 1

Recommended Treatment Algorithm

First-Line Options (Based on Anxiety Type):

For Generalized Anxiety Disorder:

• Fluvoxamine is covered by insurance for anxiety in Japan and does not cause sweating 5, 1
• Buspirone as alternative - effective as benzodiazepines without sedation, muscle relaxation, or sweating 2, 4
• Hydroxyzine - more effective than placebo (OR 0.30,95% CI 0.15 to 0.58) with drowsiness as main side effect, not sweating 3

For Social Anxiety Disorder:

• Escitalopram or sertraline are first-line per NICE guidelines, but these DO cause sweating 5
• Fluvoxamine is second-line per NICE but does NOT cause sweating - consider prioritizing this 5, 1
• Pregabalin is first-line per Canadian guidelines and not associated with sweating 5, 4

Second-Line Options:

• Benzodiazepines (alprazolam, bromazepam, clonazepam) - not associated with sweating but carry dependence risk and cognitive impairment with chronic use 5, 6
• Gabapentin - second-line agent without sweating as prominent side effect 5, 4

Critical Caveats

Important considerations when avoiding sweating:

• Most effective first-line anxiolytics (escitalopram, sertraline, paroxetine, venlafaxine) DO cause significant sweating 5, 1
• The sweating risk is not dose-dependent with SSRIs/SNRIs, so lowering the dose will not help 1
• Fluvoxamine is the only SSRI that does not increase sweating risk and is insurance-covered for anxiety 5, 1
• Benzodiazepines avoid sweating but should not be used long-term (>4 weeks) due to dependence, cognitive impairment, and withdrawal risks 6
• Buspirone lacks abuse potential and does not cause physiologic dependence, making it safer for long-term use than benzodiazepines 2

Monitoring Recommendations

• Assess for anticholinergic side effects with buspirone and hydroxyzine (dry mouth, constipation, urinary retention) 2, 3
• Monitor for sedation/drowsiness with hydroxyzine, which is the most common side effect 3
• Watch for serotonin syndrome if combining fluvoxamine with other serotonergic agents 5
• Treatment should be monitored by a physician with expertise in anxiety disorder management 5